Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test AFB-MOTT Drug Sensitivity Test (Slow Grower) is 21 days.

What are the prerequisites for the test AFB-MOTT Drug Sensitivity Test (Slow Grower)

  • Patient specimen submitted in sterile container
  • Completed laboratory requisition form
  • Properly labeled specimen with patient's name, date of birth, and collection date
  • Specimen collection date and time documented on requisition form
  • Proper specimen storage and transportation to laboratory

What are the measure values for the test AFB-MOTT Drug Sensitivity Test (Slow Grower)

  • Rifampin (RIF) - Resistant, Intermediate, Susceptible
  • Isoniazid (INH) - Resistant, Intermediate, Susceptible
  • Ethambutol (EMB) - Resistant, Intermediate, Susceptible
  • Streptomycin (STR) - Resistant, Intermediate, Susceptible
  • Pyrazinamide (PZA) - Resistant, Intermediate, Susceptible

What does this test AFB-MOTT Drug Sensitivity Test (Slow Grower) identify?

This test, AFB-MOTT Drug Sensitivity Test (Slow Grower), is used to identify the drug sensitivity of slow-growing mycobacteria such as Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium xenopi. These organisms can cause infections in humans, especially in immunocompromised individuals.

Why is this test AFB-MOTT Drug Sensitivity Test (Slow Grower) taken?

The AFB-MOTT Drug Sensitivity Test (Slow Grower) is taken to determine the susceptibility of slow-growing mycobacteria to specific antibiotics. Slow-growing mycobacteria, including Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi, are difficult to treat and can cause chronic infections.

This test helps healthcare providers choose the most effective antibiotic treatment for patients with infections caused by slow-growing mycobacteria. By identifying which antibiotics are most effective against the specific strain of bacteria, healthcare providers can tailor treatment plans to improve patient outcomes and reduce the risk of antibiotic resistance.

No FAQs available.

Customer Google Rating